文献速递系统性红斑狼疮

Notch1过度活化驱动NOX2泛素化并导致系统性红斑狼疮患者CD8+调节性T细胞功能障碍

Notch1 hyperactivity drives ubiquitination of NOX2 and dysfunction of CD8+ regulatory T cells in patients with systemic lupus erythematosus.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

研究比较SLE患者与健康人CD8+调节性T细胞的数量与功能,发现SLE患者CD8+ Treg频率降低、功能受损且NOX2表达下调,机制为Notch1活性升高促进STUB1介导的NOX2泛素化;在人源化SLE嵌合小鼠中恢复NOX2或抑制Notch1可减轻疾病严重程度。

要点

  • SLE患者CD8+ Treg频率降低且抑制功能受损,伴NOX2蛋白表达下调。
  • SLE CD8+ Treg中Notch1活性升高,上调E3泛素连接酶STUB1,促进NOX2泛素化。
  • 在人源化SLE嵌合小鼠中恢复NOX2水平或抑制Notch1活性可减轻疾病严重程度。

核心结论

  • Notch1是导致NOX2缺陷和CD8+ Treg功能障碍的细胞内在机制,可作为SLE临床管理的治疗靶点。

研究设计与样本

  • 研究纳入SLE患者与健康个体评估Treg数量与效能,体外生成CD8+CD45RA+CCR7+ Treg并以靶T细胞pZAP70水平衡量抑制能力,通过检测活化Notch1和HES1评估Notch1活性,使用Notch抑制剂DAPT、Notch1 shRNA和Notch1-ICD调控Notch1,并将SLE患者PBMCs植入免疫缺陷NSG小鼠构建人源化SLE嵌合体。

主要发现

  • SLE患者CD8+ Treg频率降低且功能受损,其NOX2下调发生于翻译后水平而非转录水平。
  • SLE CD8+ Treg显示Notch1活性升高,导致E3泛素连接酶STUB1表达增加,STUB1与NOX2结合并促进其泛素化。
  • 在人源化SLE嵌合体中,恢复NOX2水平及抑制Notch1活性可减轻疾病严重程度。

临床怎么用

  • 原文结论提出Notch1可作为SLE临床管理的治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Patients with SLE display heightened immune activation and elevated IgG autoantibody levels, indicating compromised regulatory T cell (Tregs) function. Our recent findings pinpoint CD8+ Tregs as crucial regulators within secondary lymphoid organs, operating in a NOX2-dependent mechanism. However, the specific involvement of CD8+ Tregs in SLE pathogenesis and the mechanisms underlying their role remain uncertain. METHODS: SLE and healthy individuals were enlisted to assess the quantity and efficacy of Tregs. CD8+CD45RA+CCR7+ Tregs were generated ex vivo, and their suppressive capability was gauged by measuring pZAP70 levels in targeted T cells. Notch1 activity was evaluated by examining activated Notch1 and HES1, with manipulation of Notch1 accomplished with Notch inhibitor DAPT, Notch1 shRNA, and Notch1-ICD. To create humanized SLE chimaeras, immune-deficient NSG mice were engrafted with PBMCs from SLE patients. RESULTS: We observed a reduced frequency and impaired functionality of CD8+ Tregs in SLE patients. There was a downregulation of NOX2 in CD8+ Tregs from SLE patients, leading to a dysfunction. Mechanistically, the reduction of NOX2 in SLE CD8+ Tregs occurred at a post-translational level rather than at the transcriptional level. SLE CD8+ Tregs exhibited heightened Notch1 activity, resulting in increased expression of STUB1, an E3 ubiquitin ligase that binds to NOX2 and facilitates its ubiquitination. Consequently, restoring NOX2 levels and inhibiting Notch1 activity could alleviate the severity of the disease in humanized SLE chimaeras. CONCLUSION: Notch1 is the cell-intrinsic mechanism underlying NOX2 deficiency and CD8+ Treg dysfunction, serving as a therapeutic target for the clinical management of SLE.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Yuan Z, Liu M, Zhang L, et al. Notch1 hyperactivity drives ubiquitination of NOX2 and dysfunction of CD8+ regulatory T cells in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2025. PMID: 38652598. doi:10.1093/rheumatology/keae231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。